Clinical potential of electroporation for gene therapy and DNA vaccine delivery

ABSTRACT Introduction: Electroporation allows efficient delivery of DNA into cells and tissues, thereby improving the expression of therapeutic or immunogenic proteins that are encoded by plasmid DNA. This simple and versatile method holds a great potential and could address unmet medical needs such as the prevention or treatment of many cancers or infectious diseases. Areas covered: This review explores the electroporation mechanism and the parameters affecting its efficacy. An analysis of past and current clinical trials focused on DNA electroporation is presented. The pathologies addressed, the protocol used, the treatment outcome and the tolerability are highlighted. In addition, several of the possible optimization strategies for improving patient compliance and therapeutic efficacy are discussed such as plasmid design, use of genetic adjuvants for DNA vaccines, choice of appropriate delivery site and electrodes as well as pulse parameters. Expert opinion: The growing number of clinical trials and the results already available underline the strong potential of DNA electroporation which combines both safety and efficiency. Nevertheless, it remains critical to further increase fundamental knowledge to refine future strategies, to develop concerted and common DNA electroporation protocols and to continue exploring new electroporation-based therapeutic options.

[1]  D. Klinman.  CpG DNA as a vaccine adjuvant , 2003, Expert review of vaccines.

[2]  Peter Lipp,et al.  Conceptual and technical aspects of transfection and gene delivery. , 2015, Bioorganic & medicinal chemistry letters.

[3]  J. Weiss,et al.  Immunotherapy of cancer by IL-12-based cytokine combinations , 2007, Expert opinion on biological therapy.

[4]  L. Babiuk,et al.  TLR9−/− and TLR9+/+ mice display similar immune responses to a DNA vaccine , 2004, Immunology.

[5]  Gaëlle Vandermeulen,et al.  New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  J. Gehl,et al.  Efficacy of transgene expression in porcine skin as a function of electrode choice. , 2011, Bioelectrochemistry.

[7]  M. Čemažar,et al.  Improved Specificity of Gene Electrotransfer to Skin Using pDNA Under the Control of Collagen Tissue-Specific Promoter , 2015, The Journal of Membrane Biology.

[8]  J. Miyazaki,et al.  Skin-targeted gene transfer using in vivo electroporation , 2001, Gene Therapy.

[9]  J. Plotkin,et al.  Synonymous but not the same: the causes and consequences of codon bias , 2011, Nature Reviews Genetics.

[10]  S. Ulbert,et al.  Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases , 2015, Clinical and experimental vaccine research.

[11]  Damijan Miklavcic,et al.  Hollow Microneedle Arrays for Intradermal Drug Delivery and DNA Electroporation , 2010, The Journal of Membrane Biology.

[12]  J. Gehl,et al.  Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. , 2013, Human gene therapy. Clinical development.

[13]  C. Dubuquoy,et al.  TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines. , 2005, Vaccine.

[14]  Richard Heller,et al.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  N. Chatterjee,et al.  Targeted Expression of Suicide Gene by Tissue-Specific Promoter and MicroRNA Regulation for Cancer Gene Therapy , 2013, PloS one.

[16]  M. Fons,et al.  Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis C , 2013, Molecular Therapy.

[17]  Julie Gehl,et al.  Gene electrotransfer to skin; review of existing literature and clinical perspectives. , 2010, Current gene therapy.

[18]  M. Fons,et al.  Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  T. Tötterman,et al.  DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer. , 2013, Vaccine.

[20]  L. Babiuk,et al.  Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. , 2004, Journal of biotechnology.

[21]  D. Coppola,et al.  IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  A. Bolhassani,et al.  Electroporation – Advantages and Drawbacks for Delivery of Drug, Gene and Vaccine , 2014 .

[23]  Jill Gilmour,et al.  In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers , 2011, PloS one.

[24]  N. Pavselj,et al.  DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[25]  C. Dinarello,et al.  Proinflammatory cytokines. , 2000, Chest.

[26]  D. Coppola,et al.  Evaluation of a Novel Non-Penetrating Electrode for Use in DNA Vaccination , 2011, PloS one.

[27]  D. Miklavčič,et al.  Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer , 2015, Cancer Immunology, Immunotherapy.

[28]  D. Tieleman,et al.  Atomistic simulations of pore formation and closure in lipid bilayers. , 2014, Biophysical journal.

[29]  Damijan Miklavčič,et al.  Electroporation-based applications in biotechnology. , 2015, Trends in biotechnology.

[30]  Richard Heller,et al.  Electrically mediated delivery of plasmid DNA to the skin, using a multielectrode array. , 2010, Human gene therapy.

[31]  Julie Gehl,et al.  Gene electrotransfer in clinical trials. , 2014, Methods in molecular biology.

[32]  R. Malone,et al.  Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  Richard Heller,et al.  In vivo electroporation for gene therapy. , 2006, Human gene therapy.

[34]  Damijan Miklavcic,et al.  Coupling treatment planning with navigation system: a new technological approach in treatment of head and neck tumors by electrochemotherapy , 2015, Biomedical engineering online.

[35]  T. Tsong,et al.  Schwan equation and transmembrane potential induced by alternating electric field. , 1990, Biophysical journal.

[36]  C. Schmaljohn,et al.  A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[37]  L. Heller,et al.  Electro-gene transfer to skin using a noninvasive multielectrode array. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[38]  D Miklavcic,et al.  Electrochemotherapy in treatment of tumours. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[39]  Se-Hwan Yang,et al.  Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation , 2008, Experimental & Molecular Medicine.

[40]  D. Wells,et al.  Gene Therapy Progress and Prospects: Electroporation and other physical methods , 2004, Gene Therapy.

[41]  Donald K Carter,et al.  Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. , 2013, The Journal of infectious diseases.

[42]  C. Gustafsson,et al.  You're one in a googol: optimizing genes for protein expression , 2009, Journal of The Royal Society Interface.

[43]  D Miklavcic,et al.  The importance of electric field distribution for effective in vivo electroporation of tissues. , 1998, Biophysical journal.

[44]  J. Y. Scheerlinck,et al.  Genetic adjuvants for DNA vaccines. , 2001, Vaccine.

[45]  N. Petrovsky,et al.  The future of human DNA vaccines. , 2012, Journal of biotechnology.

[46]  N. Sardesai,et al.  Tolerability of intramuscular and intradermal delivery by CELLECTRA® adaptive constant current electroporation device in healthy volunteers , 2013, Human vaccines & immunotherapeutics.

[47]  Tae Jin Kim,et al.  Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients , 2014, Nature Communications.

[48]  L. Zitvogel,et al.  Trial Watch , 2013, Oncoimmunology.

[49]  J. Wolchok,et al.  Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma , 2013, Journal of Immunotherapy for Cancer.

[50]  N. Sardesai,et al.  Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses , 2012, Science Translational Medicine.

[51]  Damijan Miklavčič,et al.  Electroporation-based technologies for medicine: principles, applications, and challenges. , 2014, Annual review of biomedical engineering.

[52]  S J White,et al.  Promoters and control elements: designing expression cassettes for gene therapy. , 2004, Current gene therapy.

[53]  D. Weiner,et al.  Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. , 2008, Vaccine.

[54]  S. El-Kamary,et al.  Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[55]  E. Karita,et al.  A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults , 2015, PloS one.

[56]  J. Weaver.  Electroporation theory. Concepts and mechanisms. , 1995, Methods in molecular biology.

[57]  D Miklavcic,et al.  Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. , 2008, Human gene therapy.

[58]  K. Okuda,et al.  Recent Developments in Preclinical DNA Vaccination , 2014, Vaccines.

[59]  J. Gehl,et al.  What you always needed to know about electroporation based DNA vaccines , 2012, Human vaccines & immunotherapeutics.

[60]  J. Fewell,et al.  Enhancement of therapeutic drug and DNA delivery into cells by electroporation* Enhancement of therapeutic drug and DNA delivery into cells by electroporation , 2003 .

[61]  Richard Gilbert,et al.  Generators and Applicators: Equipment for Electroporation , 2011 .

[62]  A. Kingsman,et al.  A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1gag-pol Gene , 2000, Journal of virology.

[63]  L. Mir,et al.  Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells , 2014, Oncoimmunology.

[64]  Marie-Pierre Rols,et al.  Electropermeabilization, a physical method for the delivery of therapeutic molecules into cells. , 2006, Biochimica et biophysica acta.

[65]  D. Weiner,et al.  Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants , 2013, Front. Immunol..

[66]  P. Pisa,et al.  Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[67]  M. Rols,et al.  Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. , 2005, Biochimica et biophysica acta.

[68]  C. Coban,et al.  Innate Immune Signaling By, Genetic Adjuvants For, Dna Vaccination , 2013 .

[69]  Michael Dallas,et al.  Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial , 2015, The Lancet.

[70]  Nikolai Petrovsky,et al.  Technologies for enhanced efficacy of DNA vaccines , 2012, Expert review of vaccines.

[71]  Véronique Préat,et al.  Skin electroporation for transdermal and topical delivery. , 2004, Advanced drug delivery reviews.

[72]  J. Chen,et al.  A pilot randomized controlled trial of dual‐plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy , 2012, Journal of viral hepatitis.

[73]  E. Angov.  Codon usage: Nature's roadmap to expression and folding of proteins , 2011, Biotechnology journal.

[74]  T. Wu,et al.  DNA vaccine for cancer immunotherapy , 2014, Human vaccines & immunotherapeutics.

[75]  D Miklavcic,et al.  Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[76]  D. Scherman,et al.  Skin-specific promoters for genetic immunisation by DNA electroporation. , 2009, Vaccine.

[77]  P. Chiarella,et al.  Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. , 2008, Expert opinion on biological therapy.

[78]  Damijan Miklavčič,et al.  Induced Transmembrane Voltage and Its Correlation with Electroporation-Mediated Molecular Transport , 2010, The Journal of Membrane Biology.

[79]  G. Andreason.  Electroporation as a technique for the transfer of macromolecules into mammalian cell lines , 1993 .